Safety and efficacy of tyrosine kinase inhibitors for the treatment of multiple sclerosis: A systematic review and meta-analysis from randomized controlled trials

BACKGROUND: Multiple sclerosis (MS), an autoimmune disease, is characterized by inflammatory demyelinating lesions in the white matter of the central nervous system. Drugs targeting tyrosine kinase, a critical component of immune cell receptor signaling, have been developed to treat MS. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Zeya, Gu, Feng, Wang, Zilan, Meng, Jiahao, Tao, Xinyu, Dai, Qiling, Wang, Wei, Liu, Meirong, Wang, Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548566/
https://www.ncbi.nlm.nih.gov/pubmed/36226084
http://dx.doi.org/10.3389/fneur.2022.933123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548566/
https://www.ncbi.nlm.nih.gov/pubmed/36226084
http://dx.doi.org/10.3389/fneur.2022.933123

Ejemplares similares